Autonomic Function in Charcot-Marie-Tooth Disease
Part of Brain & nervous system, Genetic & congenital clinical trials.
This study examines how autonomic nerves (the nerves that control automatic body functions like heart rate and blood pressure) are affected in people with CMT (Charcot-Marie-Tooth disease), a genetic nerve disorder. Understanding this may help improve treatment and quality of life for CMT patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been clinically diagnosed with CMT (Charcot-Marie-Tooth disease) or are a healthy volunteer for comparison
- If you have CMT, a genetic test must have confirmed your diagnosis
- You are between 18 and 65 years old
- You are able to complete the study tests at the beginning of the trial
- You are not pregnant or breastfeeding
- You do not have other serious brain, nerve, or mental health conditions
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study examines tremor (involuntary shaking) in people with Charcot-Marie-Tooth disease, a genetic nerve condition that affects the legs and feet. Researchers will compare people with CMT who have tremor to healthy volunteers to better understand this symptom.
This study is looking for people with Charcot-Marie-Tooth disease (a nerve condition) and healthy volunteers to track long-term changes in the body. Researchers want to see if certain biomarkers (measurable signs) can help predict how CMT progresses over time.
This study looks for new markers of early Charcot-Marie-Tooth 1A (CMT1A) disease using blood tests and special MRI scans. It aims to help understand how the disease progresses and may lead to better treatments.
This study looks at how nerves work and their structure in people with Charcot-Marie-Tooth disease, CIDP, or anti-MAG neuropathy. It may help doctors better understand these conditions.
This study follows people who have Charcot-Marie-Tooth disease (CMT) and compares them with people without it. It aims to better understand CMT, using both clinical symptoms and genetic test results, which may help future care.
This study looks at fatigue and how it affects walking and balance in people with Charcot-Marie-Tooth type 1A. By comparing results with healthy volunteers, researchers hope to better understand fatigue and find ways to help.
Hear when a new CMT1A trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.